80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Novartis's debt to equity ratio is 1.30: total debt of 48.31B USD against shareholders' equity of 37.23B USD.
- Today
- 1.30
- Average, 5 years
- 0.72
- Low, 5 years
- 0.46
- High, 5 years
- 1.30
Debt to equity = total debt ÷ shareholders' equity = 48.31B ÷ 37.23B = 1.30
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 1.30 | 48.31B | 37.23B | |
| FY2025 | 31 Dec 2025 | 0.77 | 35.38B | 46.13B |
| FY2024 | 31 Dec 2024 | 0.71 | 31.26B | 44.05B |
| FY2023 | 31 Dec 2023 | 0.56 | 26.35B | 46.67B |
| FY2022 | 31 Dec 2022 | 0.47 | 27.91B | 59.34B |
| FY2021 | 31 Dec 2021 | 0.46 | 31.03B | 67.66B |
| FY2020 | 31 Dec 2020 | 0.67 | 37.86B | 56.60B |
| FY2019 | 31 Dec 2019 | 0.53 | 29.15B | 55.47B |
| FY2018 | 31 Dec 2018 | 0.41 | 32.09B | 78.61B |
| FY2017 | 31 Dec 2017 | 0.38 | 28.43B | 74.17B |
| FY2016 | 31 Dec 2016 | 0.32 | 23.80B | 74.83B |
| FY2015 | 31 Dec 2015 | 0.28 | 21.93B | 77.05B |
| FY2014 | 31 Dec 2014 | 0.29 | 20.41B | 70.77B |
| FY2013 | 31 Dec 2013 | 0.24 | 18.02B | 74.34B |
| FY2012 | 31 Dec 2012 | 0.29 | 19.73B | 69.09B |
| FY2011 | 31 Dec 2011 | 0.31 | 20.20B | 65.84B |
| FY2010 | 31 Dec 2010 | 0.36 | 22.94B | 63.20B |
| FY2009 | 31 Dec 2009 | 0.24 | 13.91B | 57.39B |
| FY2008 | 31 Dec 2008 | 0.14 | 7.04B | 50.29B |
| FY2007 | 31 Dec 2007 | 0.11 | 5.59B | 49.22B |
| FY2006 | 31 Dec 2006 | 0.18 | 7.22B | 41.11B |
| FY2005 | 31 Dec 2005 | 0.25 | 8.21B | 32.99B |
| FY2004 | 31 Dec 2004 | 0.19 | 6.56B | 33.78B |
| FY2003 | 31 Dec 2003 | 0.18 | 5.47B | 30.43B |
| FY2002 | 31 Dec 2002 | 0.20 | 5.59B | 28.34B |
| FY2001 | 31 Dec 2001 | 0.18 | 4.57B | 25.50B |
| FY2000 | 31 Dec 2000 | 0.16 | 3.70B | 22.48B |
| FY1999 | 31 Dec 1999 | 0.27 | 6.24B | 23.41B |
| FY1998 | 31 Dec 1998 | 0.28 | 6.24B | 22.52B |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.30 | 48.31B | 37.23B |
| Q2 FY2026 | 30 Jun 2026 | 1.18 | 49.01B | 41.54B |
| Q1 FY2026 | 31 Mar 2026 | 1.22 | 47.00B | 38.51B |
| Q4 FY2025 | 31 Dec 2025 | 0.80 | 37.11B | 46.13B |
| Q3 FY2025 | 29 Sept 2025 | 0.72 | 32.02B | 44.33B |
| Q2 FY2025 | 30 Jun 2025 | 0.78 | 32.64B | 41.99B |
| Q1 FY2025 | 31 Mar 2025 | 0.81 | 31.27B | 38.37B |
| Q4 FY2024 | 31 Dec 2024 | 0.71 | 31.26B | 44.05B |
| Q3 FY2024 | 30 Sept 2024 | 0.74 | 32.16B | 43.32B |
| Q2 FY2024 | 30 Jun 2024 | 0.69 | 28.99B | 41.73B |
| Q1 FY2024 | 31 Mar 2024 | 0.69 | 27.28B | 39.68B |
| Q4 FY2023 | 31 Dec 2023 | 0.56 | 26.35B | 46.67B |
| Q3 FY2023 | 30 Sept 2023 | 0.66 | 25.19B | 38.16B |
| Q2 FY2023 | 30 Jun 2023 | 0.55 | 28.34B | 51.85B |
| Q1 FY2023 | 31 Mar 2023 | 0.56 | 29.20B | 52.06B |
| Q4 FY2022 | 31 Dec 2022 | 0.47 | 27.91B | 59.34B |
| Q3 FY2022 | 30 Sept 2022 | 0.47 | 28.54B | 60.82B |
| Q2 FY2022 | 30 Jun 2022 | 0.49 | 31.09B | 62.93B |
| Q1 FY2022 | 31 Mar 2022 | 0.51 | 31.34B | 61.54B |
| Q4 FY2021 | 31 Dec 2021 | 0.46 | 31.03B | 67.66B |
| Q3 FY2021 | 30 Sept 2021 | 0.60 | 34.33B | 56.77B |
| Q2 FY2021 | 30 Jun 2021 | 0.66 | 35.85B | 54.04B |
| Q1 FY2021 | 31 Mar 2021 | 0.75 | 37.84B | 50.52B |
| Q4 FY2020 | 31 Dec 2020 | 0.67 | 37.86B | 56.60B |
| Q3 FY2020 | 30 Sept 2020 | 0.70 | 38.18B | 54.48B |
| Q2 FY2020 | 30 Jun 2020 | 0.65 | 34.79B | 53.81B |
| Q1 FY2020 | 31 Mar 2020 | 0.72 | 36.70B | 50.90B |
| Q4 FY2019 | 31 Dec 2019 | 0.53 | 29.15B | 55.47B |
| Q3 FY2019 | 30 Sept 2019 | 0.57 | 30.12B | 52.52B |
| Q2 FY2019 | 30 Jun 2019 | 0.59 | 30.27B | 51.43B |
| Q1 FY2019 | 31 Mar 2019 | 0.65 | 30.59B | 47.23B |
| Q4 FY2018 | 31 Dec 2018 | 0.41 | 32.09B | 78.61B |
| Q3 FY2018 | 30 Sept 2018 | 0.41 | 31.78B | 77.94B |
| Q2 FY2018 | 30 Jun 2018 | 0.42 | 32.36B | 76.82B |
| Q1 FY2018 | 31 Mar 2018 | 0.48 | 34.11B | 71.10B |
| Q4 FY2017 | 31 Dec 2017 | 0.38 | 28.43B | 74.17B |
| Q3 FY2017 | 30 Sept 2017 | 0.42 | 30.16B | 72.31B |
| Q2 FY2017 | 30 Jun 2017 | 0.44 | 30.56B | 69.92B |
| Q1 FY2017 | 31 Mar 2017 | 0.46 | 31.26B | 67.59B |
| Q4 FY2016 | 31 Dec 2016 | 0.32 | 23.80B | 74.83B |
| Q3 FY2016 | 30 Sept 2016 | 0.35 | 26.57B | 74.98B |
| Q2 FY2016 | 30 Jun 2016 | 0.36 | 26.37B | 72.46B |
| Q1 FY2016 | 31 Mar 2016 | 0.39 | 28.09B | 71.81B |
| Q4 FY2015 | 31 Dec 2015 | 0.28 | 21.93B | 77.05B |
| Q3 FY2015 | 30 Sept 2015 | 0.30 | 22.70B | 76.71B |
| Q2 FY2015 | 30 Jun 2015 | 0.30 | 23.27B | 78.76B |
| Q1 FY2015 | 31 Mar 2015 | 0.33 | 25.11B | 76.38B |
| Q4 FY2014 | 31 Dec 2014 | 0.29 | 20.41B | 70.77B |
| Q3 FY2014 | 30 Sept 2014 | 0.27 | 19.61B | 71.34B |
| Q2 FY2014 | 30 Jun 2014 | 0.29 | 20.43B | 70.39B |
| Q1 FY2014 | 31 Mar 2014 | 0.30 | 21.21B | 70.21B |
| Q4 FY2013 | 31 Dec 2013 | 0.24 | 18.02B | 74.34B |
| Q3 FY2013 | 30 Sept 2013 | 0.26 | 18.78B | 72.05B |
| Q2 FY2013 | 30 Jun 2013 | 0.27 | 18.87B | 69.49B |
| Q1 FY2013 | 31 Mar 2013 | 0.31 | 20.94B | 67.03B |
| Q4 FY2012 | 31 Dec 2012 | 0.29 | 19.73B | 69.09B |
| Q3 FY2012 | 30 Sept 2012 | 0.31 | 20.84B | 67.08B |
| Q2 FY2012 | 30 Jun 2012 | 0.35 | 22.63B | 64.13B |
| Q1 FY2012 | 31 Mar 2012 | 0.39 | 24.59B | 63.11B |
| Q4 FY2011 | 31 Dec 2011 | 0.31 | 20.20B | 65.84B |
| Q3 FY2011 | 30 Sept 2011 | 0.36 | 23.89B | 66.14B |
| Q2 FY2011 | 30 Jun 2011 | 0.41 | 27.51B | 67.09B |
| Q1 FY2011 | 31 Mar 2011 | 0.48 | 31.11B | 65.34B |
| Q4 FY2010 | 31 Dec 2010 | 0.36 | 22.94B | 63.20B |
| Q3 FY2010 | 30 Sept 2010 | 0.41 | 26.96B | 66.22B |
| Q2 FY2010 | 30 Jun 2010 | 0.33 | 18.64B | 55.82B |
| Q1 FY2010 | 31 Mar 2010 | 0.32 | 17.93B | 55.22B |
| Q4 FY2009 | 31 Dec 2009 | 0.24 | 13.91B | 57.39B |
| Q3 FY2009 | 30 Sept 2009 | 0.27 | 14.37B | 53.31B |
| Q2 FY2009 | 30 Jun 2009 | 0.27 | 13.87B | 50.49B |
| Q1 FY2009 | 31 Mar 2009 | 0.25 | 11.45B | 46.23B |
| Q4 FY2008 | 31 Dec 2008 | 0.14 | 7.04B | 50.29B |
| Q3 FY2008 | 30 Sept 2008 | 0.21 | 10.80B | 50.74B |
| Q2 FY2008 | 30 Jun 2008 | 0.21 | 10.73B | 51.61B |
| Q1 FY2008 | 31 Mar 2008 | 0.13 | 6.48B | 49.27B |
| Q4 FY2007 | 31 Dec 2007 | 0.11 | 5.59B | 49.22B |
| Q3 FY2007 | 30 Sept 2007 | 0.15 | 7.24B | 49.49B |
| Q2 FY2007 | 30 Jun 2007 | 0.17 | 7.45B | 43.66B |
| Q1 FY2007 | 31 Mar 2007 | 0.18 | 7.35B | 40.50B |
| Q4 FY2006 | 31 Dec 2006 | 0.18 | 7.22B | 41.11B |
| Q3 FY2006 | 30 Sept 2006 | 0.24 | 9.22B | 38.59B |
| Q2 FY2006 | 30 Jun 2006 | 0.25 | 9.43B | 37.16B |
| Q1 FY2006 | 31 Mar 2006 | 0.24 | 8.09B | 33.75B |
| Q4 FY2005 | 31 Dec 2005 | 0.25 | 8.21B | 32.99B |
| Q3 FY2005 | 30 Sept 2005 | 0.22 | 6.90B | 31.74B |
| Q2 FY2005 | 30 Jun 2005 | 0.25 | 7.69B | 30.39B |
| Q1 FY2005 | 31 Mar 2005 | 0.21 | 6.05B | 29.46B |
| Q4 FY2004 | 31 Dec 2004 | 0.19 | 6.56B | 33.78B |
| Q3 FY2004 | 30 Sept 2004 | 0.18 | 5.53B | 30.99B |
| Q2 FY2004 | 30 Jun 2004 | 0.20 | 5.99B | 30.16B |
| Q1 FY2004 | 31 Mar 2004 | 0.22 | 6.54B | 29.33B |
| Q4 FY2003 | 31 Dec 2003 | 0.18 | 5.47B | 30.43B |
| Q3 FY2003 | 30 Sept 2003 | 0.20 | 5.62B | 28.44B |
| Q2 FY2003 | 30 Jun 2003 | 0.26 | 6.97B | 26.42B |
| Q1 FY2003 | 31 Mar 2003 | 0.21 | 5.88B | 28.01B |
| Q4 FY2002 | 31 Dec 2002 | 0.20 | 5.59B | 28.34B |
| Q3 FY2002 | 30 Sept 2002 | 0.19 | 4.92B | 25.87B |
| Q2 FY2002 | 30 Jun 2002 | 0.18 | 5.05B | 27.94B |
| Q1 FY2002 | 31 Mar 2002 | — | — | — |
| Q4 FY2001 | 31 Dec 2001 | 0.18 | 4.57B | 25.50B |
| Q3 FY2001 | 30 Sept 2001 | — | — | — |
| Q2 FY2001 | 30 Jun 2001 | 0.21 | 4.33B | 20.55B |
| Q1 FY2001 | 31 Mar 2001 | — | — | — |
| Q4 FY2000 | 31 Dec 2000 | 0.16 | 3.70B | 22.48B |
| Q3 FY2000 | 30 Sept 2000 | — | — | — |
| Q2 FY2000 | 30 Jun 2000 | 0.22 | 5.09B | 23.16B |
| Q1 FY2000 | 31 Mar 2000 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios
Common questions about Novartis's debt to equity
Source: Financial Modeling Prep